GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (STU:1KJ) » Definitions » Additional Paid-In Capital

10x Genomics (STU:1KJ) Additional Paid-In Capital : €1,898.6 Mil(As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is 10x Genomics Additional Paid-In Capital?


10x Genomics's quarterly additional paid-in capital increased from Sep. 2023 (€1,856.5 Mil) to Dec. 2023 (€1,857.7 Mil) and increased from Dec. 2023 (€1,857.7 Mil) to Mar. 2024 (€1,898.6 Mil).

10x Genomics's annual additional paid-in capital increased from Dec. 2021 (€1,487.6 Mil) to Dec. 2022 (€1,736.4 Mil) and increased from Dec. 2022 (€1,736.4 Mil) to Dec. 2023 (€1,857.7 Mil).


10x Genomics Additional Paid-In Capital Historical Data

The historical data trend for 10x Genomics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics Additional Paid-In Capital Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 614.25 1,269.35 1,487.57 1,736.39 1,857.74

10x Genomics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,759.59 1,787.62 1,856.53 1,857.74 1,898.56

10x Genomics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

10x Genomics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of 10x Genomics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


10x Genomics (STU:1KJ) Business Description

Traded in Other Exchanges
Address
6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

10x Genomics (STU:1KJ) Headlines

No Headlines